Rasilez HCT 150mg/12.5mg Filmtabletten Sveitsi - saksa - Swissmedic (Swiss Agency for Therapeutic Products)

rasilez hct 150mg/12.5mg filmtabletten

future health pharma gmbh - aliskirenum, hydrochlorothiazidum - filmtabletten - aliskirenum 150 mg bis aliskireni hemifumaras, hydrochlorothiazidum 12.5 mg, excipiens pro compresso dunst. - hypertonie - synthetika

Rasilez HCT 150mg/25mg Filmtabletten Sveitsi - saksa - Swissmedic (Swiss Agency for Therapeutic Products)

rasilez hct 150mg/25mg filmtabletten

future health pharma gmbh - aliskirenum, hydrochlorothiazidum - filmtabletten - aliskirenum 150 mg bis aliskireni hemifumaras, hydrochlorothiazidum 25 mg, excipiens pro compresso dunst. - hypertonie - synthetika

Rasilez HCT 300mg/12.5mg Filmtabletten Sveitsi - saksa - Swissmedic (Swiss Agency for Therapeutic Products)

rasilez hct 300mg/12.5mg filmtabletten

future health pharma gmbh - aliskirenum, hydrochlorothiazidum - filmtabletten - aliskirenum 300 mg bis aliskireni hemifumaras, hydrochlorothiazidum 12.5 mg, excipiens pro compresso dunst. - hypertonie - synthetika

Rasilez HCT 300mg/25mg Filmtabletten Sveitsi - saksa - Swissmedic (Swiss Agency for Therapeutic Products)

rasilez hct 300mg/25mg filmtabletten

future health pharma gmbh - aliskirenum, hydrochlorothiazidum - filmtabletten - aliskirenum 300 mg bis aliskireni hemifumaras, hydrochlorothiazidum 25 mg, excipiens pro compresso dunst. - hypertonie - synthetika

Rasilez 150 mg Filmtabletten Sveitsi - saksa - Swissmedic (Swiss Agency for Therapeutic Products)

rasilez 150 mg filmtabletten

future health pharma gmbh - aliskirenum - filmtabletten - aliskirenum 150 mg ut aliskireni hemifumaras, cellulosum microcristallinum, crospovidonum, povidonum k 30, silica colloidalis anhydrica, magnesii stearas, Überzug: macrogolum 4000, talcum, hypromellosum, e 171, e 172 (rubrum), e 172 (nigrum), pro compresso obducto. - behandlung der essentiellen hypertonie - synthetika

Rasilez 300 mg Filmtabletten Sveitsi - saksa - Swissmedic (Swiss Agency for Therapeutic Products)

rasilez 300 mg filmtabletten

future health pharma gmbh - aliskirenum - filmtabletten - aliskirenum 300 mg ut aliskireni hemifumaras, cellulosum microcristallinum, crospovidonum, povidonum k 30, silica colloidalis anhydrica, magnesii stearas, Überzug: macrogolum 4000, talcum, hypromellosum, e 171, e 172 (rubrum), e 172 (nigrum), pro compresso obducto. - behandlung der essentiellen hypertonie - synthetika

Miacalcic mite 100 Nasenspray Sveitsi - saksa - Swissmedic (Swiss Agency for Therapeutic Products)

miacalcic mite 100 nasenspray

future health pharma gmbh - calcitoninum salmonis - nasenspray - calcitoninum salmonis 100 u.i., natrii chloridum, acidum hydrochloridum 25 per centum, benzalkonii chloridum 0.009 mg, aqua purificata, ad solutionem pro dosi. - osteoporoseprävention, morbus paget, neurodystrophische störungen - synthetika

Miacalcic 200 Nasenspray Sveitsi - saksa - Swissmedic (Swiss Agency for Therapeutic Products)

miacalcic 200 nasenspray

future health pharma gmbh - calcitoninum salmonis - nasenspray - calcitoninum salmonis 200 u.i., natrii chloridum, acidum hydrochloridum 25 per centum, benzalkonii chloridum 0.009 mg, aqua purificata, ad solutionem pro dosi. - osteoporoseprävention, morbus paget, neurodystrophische störungen - synthetika

Xermelo 250 mg Filmtabletten Sveitsi - saksa - Swissmedic (Swiss Agency for Therapeutic Products)

xermelo 250 mg filmtabletten

future health pharma gmbh - ethylis telotristatas - filmtabletten - ethylis telotristatas 250 mg ut telotristati etipras 327.9 mg corresp. telotristatum 237.80 mg, lactosum 167.91 mg, hydroxypropylcellulosum, carmellosum natricum conexum, natrium 4.54 mg, magnesii stearas, silica colloidalis, Überzug: poly(alcohol vinylicus), macrogolum 3350, talcum, e 171, pro compresso obducto. - karzinoid-syndrom-bedingte diarrhö - synthetika

Lundeos Weichkapseln Sveitsi - saksa - Swissmedic (Swiss Agency for Therapeutic Products)

lundeos weichkapseln

future health pharma gmbh - cholecalciferolum - weichkapseln - cholecalciferolum 20000 u.i. corresp. cholecalciferolum 500 µg, triglycerida media, int-rac-alpha-tocopherylis acetas, gelatina, glycerolum, sorbitolum liquidum partim deshydricum corresp. sorbitolum max. 3.64 mg, aqua purificata, pro capsula. - therapie des vitamin d-mangels bei erwachsenen und jugendlichen ab 12 jahren.; prophylaxe eines vitamin d-mangels bei erwachsenen bis 60 jahren und jugendlichen ab 12 jahren. - synthetika